Berodual 0.25 mg / 0.5 mg per mL

Indication

Prevention and treatment of symptoms in chronic obstructive airway disorders with reversible bronchospasm, such as bronchial asthma and chronic obstructive pulmonary disease (COPD).

Ingredients

• Ipratropium bromide anhydrous 0.025% w/v (250 micrograms per mL)
• Fenoterol hydrobromide 0.05% w/v (500 micrograms per mL)

Direction

For oral inhalation only via nebuliser. Use as directed by a physician. The dose should be adjusted to individual requirements and diluted with sterile saline as instructed. 1 mL = 20 drops.

Side effects

• Cough
• dry mouth
• throat irritation
• Headache
• dizziness
• tremor
• Nervousness
• palpitations and increased heart rate
• Nausea and vomiting
• Consult a doctor or pharmacist before use
• stop if irritation or allergy occurs

Precautions

• Use with caution in patients with cardiovascular disorders
• hyperthyroidism
• diabetes or glaucoma
• Avoid contact with the eyes
• Seek medical advice if breathing worsens or relief is not obtained
• Consult a doctor or pharmacist before use
• stop if irritation or allergy occurs